Varco® Leg Care has raised an undisclosed amount in its seed round of funding led by Mr. Neeraj Garg, former CEO of Hindustan Coca-Cola. The company will use the money to expand its product line and invest in cutting-edge technology to improve leg health.
Healthcare startup, Varco® Leg Care, has successfully raised an undisclosed amount in its seed round of funding. Based in Delhi, Varco® Leg Care, has been established on the basis of advanced scientific research and the use of Nobel Prize-winning phytotechnology.
The funding was led by Mr. Neeraj Garg, former CEO of Hindustan Coca-Cola, and included participation from Dr. Mohit Lalvani of Mascot Spincontrol India Pvt Ltd, Simple Juneja, a global business leader with experience at Coca-Cola, Bacardi, and LVMH, as well as other medical angels, top consultant companies, FMCG, and infrastructure investors.
Varco® Leg Care has announced plans to expand its product line with a focus on improving leg health, following a recent infusion of funding. The company has announced its plans to invest in cutting-edge technology to boost retention and discoverability, all the while improving its distribution channels. Varco® has announced its plans to expand its business operations in the United States and UAE by recruiting more key opinion leaders in high-performing markets. The company also intends to allocate significant resources to research and development efforts.
During the event, Mr. Anondeep Ganguly, CEO of Varco® Leg Care, announced that the company has undertaken an extensive research and development program to create Asia’s first phyto-based leg care brand. Dr. Apurba Ganguly, the Chief Scientific Officer, has led the initiative with over 100 clinical studies published in esteemed medical journals. Dr. Ganguly is also a distinguished member of the American Academy of Pain Medicine and the European Medical Association. The company’s goal is to establish itself as the top brand in the industry by exclusively catering to the genuine needs of leg care.
In a recent development, it has been announced that Dr. Tapish Sahu has been appointed as the Chief Medical Advisor of the organization. The company expressed their pride in making this announcement. Renowned Vascular Surgeon, Dr. Sahu, has been appointed as a key advisor to aid in the development of our product line. His expertise in the field is highly regarded and will undoubtedly prove to be an invaluable asset to our team.
According to Ganguly, the company plans to utilize advanced formulations and proprietary phytotransdermal technology to offer innovative solutions for a range of leg health issues, including varicose veins, diabetic feet, and nail fungus. The approach will involve taking the KOL (Key Opinion Leader) route under his guidance to cater to these conditions and provide end-to-end leg health solutions.
According to Mr. Neeraj Garg, former CEO of Hindustan Coca-Cola, the product in question has been scientifically validated not only in India, but also in the United States and Europe. He expressed his belief that it is an excellent product. As the online journey gains momentum, the focus now shifts towards establishing distribution channels that span from direct-to-consumer (D2C) to a physical-digital (Phygital) model, in order to fully realize its commercial potential. According to the source, there is a strong belief that this brand has the potential to generate $10 million in revenue within the next 3-4 years.
Varco® Leg Care, India’s pioneering brand that concentrates solely on leg care, was established in 2022 with the objective of tackling leg health issues from start to finish. In a stunning accomplishment, Varco® Leg Care has secured a spot on Walmart’s esteemed platform, making it one of the select Indian brands to achieve this feat in a mere few months since its launch. Varco® Leg Care has achieved a remarkable feat with a notable growth rate of 30% month over month.
Varco® Leg Care is making strides in the leg care industry by focusing on the creation of a comprehensive and effective product line. In addition, the company is aiming to solidify its presence in the US market by forming strategic alliances with top marketplaces. The company has set its sights on dominating the leg care section in pharmacies worldwide.
To achieve this, it plans to first accomplish its initial objective and then utilize data-driven decision-making to expand its presence into retail channels. The company’s ambitious long-term vision and commitment to delivering innovative and effective products to customers worldwide is reflected in this approach.
